TrialThe oncologist2023

The Phase II Study of Panitumumab in Chemotherapy-Naïve Frail or Elderly Patients with RAS Wild-type Colorectal Cancer: OGSG 1602 Final Results.

Tetsuji Terazawa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.